Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Saunders

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2003
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementiaEric M Reiman, Kewei Chen, Gene E Alexander, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2005
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolismEric M Reiman, Kewei Chen, Gene E Alexander, et al.
Journal of Lipid Research|May 20, 2003
ApoE genotype-specific inhibition of apoptosisRobert M DeKroon, Mirta Mihovilovic, Zoe V Goodger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 1, 2017
The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative diseasePeter A Larsen, Michael W Lutz, Kelsie E Hunnicutt, et al.
Journal of Parkinson'S Disease and Alzheimer'S Disease|March 7, 2015
The Broad Impact of TOM40 on Neurodegenerative Diseases in AgingWilliam K Gottschalk, Michael W Lutz, Yu Ting He, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2023
TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 HomozygotesAmber Watts, Stephen Haneline, Kathleen A Welsh-Bohmer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2012
Longitudinal modeling of cognitive aging and the TOMM40 effectRichard J Caselli, Amylou C Dueck, Matthew J Huentelman, et al.
Dementia and Geriatric Cognitive Disorders|August 25, 2010
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyMichael Gold, Claire Alderton, Marina Zvartau-Hind, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 6, 2016
A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's DiseaseMichael W Lutz, Scott S Sundseth, Daniel K Burns, et al.
Neurobiology of Aging|October 24, 2002
APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stressCarol A Colton, Candice M Brown, Danielle Cook, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2003
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementiaEric M Reiman, Kewei Chen, Gene E Alexander, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2005
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolismEric M Reiman, Kewei Chen, Gene E Alexander, et al.
Journal of Lipid Research|May 20, 2003
ApoE genotype-specific inhibition of apoptosisRobert M DeKroon, Mirta Mihovilovic, Zoe V Goodger, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 1, 2017
The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative diseasePeter A Larsen, Michael W Lutz, Kelsie E Hunnicutt, et al.
Journal of Parkinson'S Disease and Alzheimer'S Disease|March 7, 2015
The Broad Impact of TOM40 on Neurodegenerative Diseases in AgingWilliam K Gottschalk, Michael W Lutz, Yu Ting He, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2023
TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 HomozygotesAmber Watts, Stephen Haneline, Kathleen A Welsh-Bohmer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2012
Longitudinal modeling of cognitive aging and the TOMM40 effectRichard J Caselli, Amylou C Dueck, Matthew J Huentelman, et al.
Dementia and Geriatric Cognitive Disorders|August 25, 2010
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyMichael Gold, Claire Alderton, Marina Zvartau-Hind, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 6, 2016
A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's DiseaseMichael W Lutz, Scott S Sundseth, Daniel K Burns, et al.
Neurobiology of Aging|October 24, 2002
APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stressCarol A Colton, Candice M Brown, Danielle Cook, et al.
Pageof 6